The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates

Eid, Deeb; Meagher, Rebecca C; Lengel, Aaron J.

doi:10.4140/tcp.n.2015.459

Cited by 7 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study adds to evidence on the pivotal role of provider recommendations regarding getting the shingles vaccine. Consistent with other studies, receiving advice from a GP or another healthcare provider (HCP) to get the shingles vaccine increases acceptability of the vaccine [15,16,21,38,39], and may even reverse initial reluctance towards the shingles vaccination [14].…”

Section: Discussionmentioning

confidence: 57%

Determinants of shingles vaccine acceptance in the United Kingdom

et al. 2019

View full text Add to dashboard Cite

Background The United Kingdom (UK) was the first European country to introduce a national immunisation program for shingles (2013–2014). That year, vaccination coverage ranged from 50 to 64% across the UK, but uptake has declined ever since. This study explored determinants of the acceptance of the shingles vaccine in the UK. Methods Vaccinated and unvaccinated individuals, who were eligible for the last catch-up cohort of the 2014–2015 shingles vaccination campaign, were identified using the Clinical Practice Research Datalink (the National Health Service data research service) and invited to participate by their general practitioner (GP). An anonymised self-administered questionnaire was developed using the Health Belief Model as a theoretical framework, to collect data on demographic and socio-economic characteristics, health status, knowledge, influences, experiences and attitudes to shingles and the shingles vaccine. Multivariable logistic regression was used to identify the factors associated with vaccination. Physicians’ views concerning perceived barriers to vaccination were also assessed. Results Of the 2,530 questionnaires distributed, 536 were returned (21.2%) from 69 general practices throughout the UK. The majority of responders were female (58%), lived in care homes (56%) and had completed secondary or higher education (88%). There were no differences between vaccinated and unvaccinated responders. Being offered the shingles vaccine by a GP/nurse (odds ratio (OR) = 2.3), and self-efficacy (OR = 1.2) were associated with being vaccinated (p<0.05). In contrast, previous shingles history (OR = 0.4), perceived barriers to vaccination (OR = 0.7) and perceived control of the disease (OR = 0.7) were associated with not being vaccinated against shingles (p<0.05). Less than half (44.0%) of GPs were aware of the local communication campaigns regarding shingles and the shingles vaccine. Conclusions Socio-psychological factors largely influence shingles vaccination acceptance in this study. The results add to existing evidence that healthcare providers (HCPs) have a pivotal role against vaccine hesitancy. Campaigns focusing on GPs and accessible information offered to eligible members of the public can further enhance shingles vaccine uptake.

show abstract

Section: Discussionmentioning

confidence: 57%

Determinants of shingles vaccine acceptance in the United Kingdom

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Concerning the perspectives of the evolution of recommendations, only about 50% of participants were in favor of a mandatory vaccination or a school-based program. These rates are much lower than those found in other European countries; 77% of gynecologists in Poland [ 83 ] and 91% of health professionals in Italy [ 85 ] are in favor of mandatory vaccination. In addition, several studies suggest that American [ 86 , 87 ] and Australian parents tend to support school-based vaccination programs for their children [ 88 ].…”

Section: Discussionmentioning

confidence: 71%

“…This interest in summary leaflets has also been shown among GPs and pharmacists in New Zealand [ 80 ] and Canada [ 75 ]. In addition, several studies have demonstrated their effectiveness in increasing the acceptability of HPV vaccination [ 81 , 82 ], Herpes Zoster vaccination [ 83 ], or the proper use of antibiotics [ 84 ].…”

Section: Discussionmentioning

confidence: 99%

Human Papillomaviruses in Adolescents: Knowledge, Attitudes, and Practices of Pharmacists Regarding Virus and Vaccination in France

Dufour

Carrouel

Deroanne

2023

Viruses

View full text Add to dashboard Cite

Human papillomaviruses (HPVs) are responsible for one of the most common sexually transmitted diseases in the world, and their oncogenic role has been well demonstrated in genital, anal, and oropharyngeal areas. However, a certain distrust and a lack of knowledge about this vaccine are perceptible among French adolescents and their parents. Thus, health professionals and, more particularly, pharmacists appear to be key persons to promote HPV vaccination and restore confidence in the target population. The present study aims to assess the knowledge, attitudes, and practices regarding HPV vaccination among pharmacists, particularly in boys, following the 2019 recommendation to vaccinate them. The present study was designed as a cross-sectional, quantitative, and descriptive survey that was conducted from March to September 2021 among pharmacists in France. 215 complete questionnaires were collected. Gaps in knowledge were found, only 21.4% and 8.4% obtained a high level of knowledge related to, respectively, HPV and vaccination. Pharmacists were confident in the HPV vaccine (94.4%), found it safe and useful, and felt that the promotion of the vaccine was part of their role (94.0%). However, only a few have already advised it, which they justify due to a lack of opportunity and forgetfulness. Faced with this, training, computerized reminders, or supportive materials could be implemented to improve the advice and thus the vaccination coverage. Finally, 64.2% were in favor of a pharmacy-based vaccination program. In conclusion, pharmacists are interested in this vaccination and the role of promoter. However, they need the means to facilitate this mission: training, computer alerts, supportive materials such as flyers, and the implementation of vaccination in pharmacies.

show abstract

“…This is consistent with existing research that demonstrated receiving a recommendation, advice, and education from HCPs improves HZ vaccine uptake and adherence. 11 , 27–29 …”

Section: Discussionmentioning

confidence: 99%

Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients

George,

Regan,

Awan

et al. 2024

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

This qualitative, cross-sectional study aimed to understand the barriers and facilitators related to the adherence and completion of the recombinant zoster vaccine (RZV) two-dose series in Canada, as perceived by healthcare providers (HCPs) and patients. Data collection occurred via 60-minute concept elicitation interviews with 12 HCPs (4 physicians, 2 nurse practitioners, 6 pharmacists) who had prescribed and/or administered RZV in Canada, and 21 patients aged ≥50 years who had received ≥1 dose of RZV. Patients were categorized as adherent (received both doses within the recommended 2-to-6-month timeframe; n = 11) or non-adherent (received only one dose or second dose outside the recommended timeframe; n = 10). Interview transcripts were coded and analyzed using a two-part thematic analysis approach. HCP-identified barriers to RZV adherence included high out-of-pocket cost, inconsistent/lack of health plan coverage, inconvenient processes for accessing RZV, and patient forgetfulness. HCP-identified facilitators included desire for shingles protection, HCP encouragement, and reminders. Barriers to RZV adherence identified by patients included lack of HCP knowledge/experience with RZV, receiving unreliable/confusing information, having unpleasant/severe side effects following the first dose, high out-of-pocket cost, lack of insurance coverage, and forgetfulness. Patient-identified facilitators included self-motivation, financial support, convenient processes for obtaining RZV, and reminders. In conclusion, many factors can influence RZV series completion and adherence among adults in Canada, including cost, insurance coverage, HCP knowledge and encouragement, and reminders. Awareness of these factors may inform HCPs in helping patients overcome barriers and identify opportunities for future consideration, facilitating protection against herpes zoster.

show abstract

The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates

Cited by 7 publications

References 0 publications

Determinants of shingles vaccine acceptance in the United Kingdom

Determinants of shingles vaccine acceptance in the United Kingdom

Human Papillomaviruses in Adolescents: Knowledge, Attitudes, and Practices of Pharmacists Regarding Virus and Vaccination in France

Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients

Contact Info

Product

Resources

About